These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1996409)

  • 1. Conglutinin binds the HIV-1 envelope glycoprotein gp 160 and inhibits its interaction with cell membrane CD4.
    Andersen O; Sørensen AM; Svehag SE; Fenouillet E
    Scand J Immunol; 1991 Jan; 33(1):81-8. PubMed ID: 1996409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular interaction between HIV-1 major envelope glycoprotein and dextran sulfate.
    Mbemba E; Chams V; Gluckman JC; Klatzmann D; Gattegno L
    Biochim Biophys Acta; 1992 Jan; 1138(1):62-7. PubMed ID: 1371075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lectin-carbohydrate interactions and infectivity of human immunodeficiency virus type 1 (HIV-1).
    Gattegno L; Ramdani A; Jouault T; Saffar L; Gluckman JC
    AIDS Res Hum Retroviruses; 1992 Jan; 8(1):27-37. PubMed ID: 1736938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccinia virus vectors for study of membrane fusion mediated by human immunodeficiency virus envelope glycoprotein and CD4.
    Ashorn P; Berger EA; Moss B
    Methods Enzymol; 1993; 221():12-8. PubMed ID: 8361369
    [No Abstract]   [Full Text] [Related]  

  • 5. N-Acetyl-beta-D-glucosaminyl-binding properties of the envelope glycoprotein of human immunodeficiency virus type 1.
    Gattegno L; Sadeghi H; Saffar L; Bladier D; Clerget-Raslain B; Gluckman JC; Bahraoui E
    Carbohydr Res; 1991 Jun; 213():79-93. PubMed ID: 1682045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbohydrate binding properties of the envelope glycoproteins of human immunodeficiency virus type 1.
    Haidar M; Seddiki N; Gluckman JC; Gattegno L
    Glycoconj J; 1992 Dec; 9(6):315-23. PubMed ID: 1284814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine-induced antibodies to native and recombinant human immunodeficiency virus type 1 envelope glycoproteins. NIAID AIDS Vaccine Clinical Trials Network.
    Gorse GJ; Frey SE; Patel G; Newman FK; Belshe RB
    Vaccine; 1994 Aug; 12(10):912-8. PubMed ID: 7975833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of gp160 and CD4 maturation in U937 cells after both defective and productive infections by human immunodeficiency virus type 1.
    Bour S; Boulerice F; Wainberg MA
    J Virol; 1991 Dec; 65(12):6387-96. PubMed ID: 1942241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 gp41 contains two sites for interaction with several proteins on the helper T-lymphoid cell line, H9.
    Chen YH; Ebenbichler C; Vornhagen R; Schulz TF; Steindl F; Böck G; Katinger H; Dierich MP
    AIDS; 1992 Jun; 6(6):533-9. PubMed ID: 1388873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation and stability of mature HIV envelope glycoprotein conformation under various conditions.
    Papandreou MJ; Idziorek T; Miquelis R; Fenouillet E
    FEBS Lett; 1996 Jan; 379(2):171-6. PubMed ID: 8635586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of HIV membrane reconstituted from its recombinant gp160 envelope glycoprotein.
    Cornet B; Decroly E; Thines-Sempoux D; Ruysschaert JM; Vandenbranden M
    AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1823-31. PubMed ID: 1457195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
    LaBonte JA; Madani N; Sodroski J
    J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
    Guo HG; Veronese FM; Tschachler E; Pal R; Kalyanaraman VS; Gallo RC; Reitz MS
    Virology; 1990 Jan; 174(1):217-24. PubMed ID: 2104682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells.
    Travis BM; Dykers TI; Hewgill D; Ledbetter J; Tsu TT; Hu SL; Lewis JB
    Virology; 1992 Jan; 186(1):313-7. PubMed ID: 1727607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mannosyl/N-acetyl-beta-D-glucosaminyl binding properties of the envelope glycoprotein of human immunodeficiency virus type 2.
    Haïdar M; Gluckman JC; Gattegno L
    Glycobiology; 1992 Oct; 2(5):429-35. PubMed ID: 1281021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and characterization of a functional human immunodeficiency virus envelope glycoprotein in insect cells.
    Wells DE; Compans RW
    Virology; 1990 Jun; 176(2):575-86. PubMed ID: 2111957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular membrane traffic of human immunodeficiency virus type 1 envelope glycoproteins: vpu liberates Golgi-targeted gp160 from CD4-dependent retention in the endoplasmic reticulum.
    Kimura T; Nishikawa M; Ohyama A
    J Biochem; 1994 May; 115(5):1010-20. PubMed ID: 7961587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium requirement and inhibitor spectrum for intracellular HIV type 1 gp160 processing in cultured HeLa cells and CD4+ lymphocytes: similarity to those of viral envelope glycoprotein maturase.
    Kamoshita K; Shiota M; Sasaki M; Koga Y; Okumura Y; Kido H
    J Biochem; 1995 Jun; 117(6):1244-53. PubMed ID: 7490267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the interaction of HIV-1 and HIV-2 envelope glycoproteins with the CD4 receptor and role of N-glycans.
    Bahraoui E; Benjouad A; Guetard D; Kolbe H; Gluckman JC; Montagnier L
    AIDS Res Hum Retroviruses; 1992 May; 8(5):565-73. PubMed ID: 1515210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD4 anti-idiotype antibodies in volunteers immunized with rgp160 of HIV-1 or infected with HIV-1.
    Keay S; Tacket CO; Murphy JR; Handwerger BS
    AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1091-8. PubMed ID: 1503823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.